Kosyakova N V
The purpose of the study was to conduct an organizational and economic assessment of preferential drug provision for patients suffering from diabetes mellitus (DM) in the Rostov region. Materials and methods. During the study, monitoring data of the Ministry of Health of the Rostov Region on the implementation of preferential drug provision were used. Methods of structural-logical, comparative analysis and determination of average indicators were used. Conclusion. An organizational and economic assessment of preferential drug provision (LLO) of patients suffering from diabetes in the Rostov region was carried out. A description of the number of patients entitled to state support measures in terms of drug provision was given. It was found that only about 20% of the federal beneficiaries retained the right to receive medicines at the expense of the federal budget. For drug therapy of patients, 9 schemes are used Treatment, medical care in the region for patients with diabetes is provid- ed by 191 endocrinologists, as well as therapists and pediatricians, 199 endo- crinological beds have been deployed for patients with severe complications of the consequences of diabetes. The financial costs of LPOs from the regional budget exceed almost 2 times the costs of federal beneficiaries, the number of which is almost three times less than the number of regional ones. The cost per regional beneficiary is 12,099.19 rubles, which is 21.9% higher than the cost of a beneficiary under a federal benefit (9926.9 rubles). When studying the cost structure of hypoglycemic drugs, the predominance of costs for in- sulin analogues in the range was established. It should be pointed out that, in addition to hypoglycemic drugs, beneficiaries are provided with test strips for determining blood sugar levels at home and consumables for insulin pumps.
The study of the main economic processes of the pharmacy organization was carried out and quantitative indicators were obtained. The structure of inventory items is dominated by medicines and medical devices. Benchmarking found a 36.7% decrease in retail turnover, a decrease in real- ized income from 19.7% to 17.8% and an increase of 7.7% in expenses over the same period. The level of the trade margin on goods amounted to in 2021. 20.96%, and in 2022. already 18.68%, there is a decrease in the margin on medical devices, suture material and specialized nutrition. The current situation contributed to the formation of a loss from sales in 2022.
The purpose of the study was to conduct an organizational and economic assessment of preferential drug provision for patients suffering from diabetes mellitus (DM) in the Rostov region. Materials and methods. During the study, monitoring data of the Ministry of Health of the Rostov Region on the implementation of preferential drug provision were used. Methods of structural-logical, comparative analysis and determination of average indicators were used. Conclusion. An organizational and economic assessment of preferential drug provision (LLO) of patients suffering from diabetes in the Rostov region was carried out. A description of the number of patients entitled to state support measures in terms of drug provision was given. It was found that only about 20% of the federal beneficiaries retained the right to receive medicines at the expense of the federal budget. For drug therapy of patients, 9 schemes are used Treatment, medical care in the region for patients with diabetes is provid- ed by 191 endocrinologists, as well as therapists and pediatricians, 199 endo- crinological beds have been deployed for patients with severe complications of the consequences of diabetes. The financial costs of LPOs from the regional budget exceed almost 2 times the costs of federal beneficiaries, the number of which is almost three times less than the number of regional ones. The cost per regional beneficiary is 12,099.19 rubles, which is 21.9% higher than the cost of a beneficiary under a federal benefit (9926.9 rubles). When studying the cost structure of hypoglycemic drugs, the predominance of costs for in- sulin analogues in the range was established. It should be pointed out that, in addition to hypoglycemic drugs, beneficiaries are provided with test strips for determining blood sugar levels at home and consumables for insulin pumps.
The study of the main economic processes of the pharmacy organization was carried out and quantitative indicators were obtained. The structure of inventory items is dominated by medicines and medical devices. Benchmarking found a 36.7% decrease in retail turnover, a decrease in real- ized income from 19.7% to 17.8% and an increase of 7.7% in expenses over the same period. The level of the trade margin on goods amounted to in 2021. 20.96%, and in 2022. already 18.68%, there is a decrease in the margin on medical devices, suture material and specialized nutrition. The current situation contributed to the formation of a loss from sales in 2022.
